A detailed history of Goldman Sachs Group Inc transactions in Cellebrite Di Ltd. stock. As of the latest transaction made, Goldman Sachs Group Inc holds 388,150 shares of CLBT stock, worth $7.88 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
388,150
Previous 1,345,811 71.16%
Holding current value
$7.88 Million
Previous $16.1 Million 59.36%
% of portfolio
0.0%
Previous 0.0%

Shares

18 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$11.61 - $17.52 $11.1 Million - $16.8 Million
-957,661 Reduced 71.16%
388,150 $6.54 Million
Q2 2024

Aug 13, 2024

BUY
$10.38 - $12.5 $8.41 Million - $10.1 Million
810,221 Added 151.28%
1,345,811 $16.1 Million
Q1 2024

May 15, 2024

BUY
$8.04 - $12.29 $1.93 Million - $2.95 Million
239,816 Added 81.08%
535,590 $5.93 Million
Q4 2023

Feb 13, 2024

BUY
$6.45 - $8.76 $1.28 Million - $1.74 Million
199,107 Added 205.97%
295,774 $2.56 Million
Q3 2023

May 14, 2024

SELL
$6.86 - $8.18 $1.37 Million - $1.63 Million
-199,107 Reduced 67.32%
96,667 $739,000
Q3 2023

Nov 14, 2023

BUY
$6.86 - $8.18 $531,704 - $634,015
77,508 Added 404.55%
96,667 $739,000
Q2 2023

May 14, 2024

SELL
$5.3 - $7.2 $591,034 - $802,915
-111,516 Reduced 85.34%
19,159 $137,000
Q2 2023

Aug 14, 2023

SELL
$5.3 - $7.2 $591,034 - $802,915
-111,516 Reduced 85.34%
19,159 $137,000
Q1 2023

May 14, 2024

BUY
$4.36 - $6.15 $419,139 - $591,217
96,133 Added 278.31%
130,675 $795,000
Q1 2023

May 11, 2023

BUY
$4.36 - $6.15 $419,139 - $591,217
96,133 Added 278.31%
130,675 $795,000
Q4 2022

May 14, 2024

SELL
$3.99 - $4.95 $64,622 - $80,170
-16,196 Reduced 31.92%
34,542 $150,000
Q4 2022

Feb 13, 2023

SELL
$3.99 - $4.95 $64,622 - $80,170
-16,196 Reduced 31.92%
34,542 $150,000
Q3 2022

May 14, 2024

BUY
$0.75 - $5.95 $19,805 - $157,121
26,407 Added 108.53%
50,738 $199,000
Q3 2022

Nov 10, 2022

BUY
$0.75 - $5.95 $19,805 - $157,121
26,407 Added 108.53%
50,738 $198,000
Q2 2022

May 14, 2024

SELL
$4.46 - $7.19 $1.21 Million - $1.95 Million
-271,443 Reduced 91.77%
24,331 $124,000
Q2 2022

Aug 15, 2022

BUY
$4.46 - $7.19 $2,510 - $4,047
563 Added 2.37%
24,331 $124,000
Q1 2022

May 16, 2022

BUY
$5.34 - $8.12 $9,168 - $13,942
1,717 Added 7.79%
23,768 $152,000
Q4 2021

Feb 14, 2022

BUY
$7.8 - $11.24 $171,997 - $247,853
22,051 New
22,051 $177,000

Others Institutions Holding CLBT

About Cellebrite DI Ltd.


  • Ticker CLBT
  • Exchange NASDAQ
  • Sector Technology
  • Industry Software—Infrastructure
  • Shares Outstandng 189,648,992
  • Market Cap $3.85B
  • Description
  • Cellebrite DI Ltd. develops solutions for legally sanctioned investigations. Its DI platform allows users to collect, review, analyze, and manage digital data across the investigative lifecycle with respect to legally sanctioned investigations and solutions are used in a various case, including child exploitation, homicide, anti-terror, border c...
More about CLBT
Track This Portfolio

Track Goldman Sachs Group Inc Portfolio

Follow Goldman Sachs Group Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Goldman Sachs Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Goldman Sachs Group Inc with notifications on news.